HR 1885
106th Congress
House
Health
Administrative procedure
Business records
Commerce
Department of Health and Human Services
Drug approvals
Drug industry
Exports
Foreign Trade and International Finance
Government Operations and Politics
Government paperwork
Imports
Labeling
Law
International Prescription Drug Parity Act
Introduced: May 20, 1999
See on congress.gov
Everywhere this bill has been
4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Apr 12, 2000
Sponsor introductory remarks on measure. (CR H2186-2187)
Jun 15, 1999
Referred to the Subcommittee on Health and Environment.
May 20, 1999
Referred to the House Committee on Commerce.
May 20, 1999
Introduced in House
Plain-English summary
International Prescription Drug Parity Act - Amends the Federal Food, Drug, and Cosmetic Act to require manufacturers of certain drugs manufactured and domestically approved and then exported, or domestically approved and manufactured in a registered foreign establishment, to: (1) maintain specified shipment compliance and labeling records; and (2) make such records available to U.S. importers.
Directs the Secretary of Health and Human Services to establish related criteria to facilitate the U.S. importation of such drugs.
What's happening now
Sponsor introductory remarks on measure. (CR H2186-2187)
Committees of jurisdiction
2